Out-patient management of febrile neutropenia.
Fever and neutropenia commonly complicated cytotoxic cancer therapy. Although standard therapy is empirical in-patient broad-spectrum intravenous antibiotic therapy until fever and neutropenia resolve, different treatments based on patient risk have been reported over the last decade. The data identifying low risk patients, treatment strategies for low risk patients, and additional information required before recommending out-patient management of fever and neutropenia widely are described.
Talcott
J A
JA
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jtalcott@partners.org
D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005334:Fever / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors
D000900:Anti-Bacterial Agents